Prognostic value of perioperative assessment of plasma cardiac troponin I in patients undergoing liver transplantation.

An elevation in plasma cardiac troponins is an indicator of increased perioperative risk in orthopaedic and vascular surgery, however, data on liver transplantation (LTx) are scarce. The aim of the study was to evaluate the prevalence of cardiac troponin I (cTnI) elevation in the perioperative period of LTx, and its potential relationship with 1-year mortality. MATERIAL AND METHODS Analysis included 79 patients with liver cirrhosis. During LTx all patients underwent hemodynamic measurements. cTnI level was determined before the operation, 24, 48 and 72 hours afterwards. One-year mortality was assessed. RESULTS 12.7% patients died, all during in-hospital period. cTnI level on day 1. was identified as the most promising marker of increased death risk with optimal cut-off value of 0.215 ng/mL (the sensitivity of 60.0%, specificity of 87.0%, positive predictive value of 40.0%, negative predictive value of 93.8%). The most important predictor of cTnI increase was the duration of the LTx procedure followed by amount of packed red blood cells transfused, basic stroke volume index, and cardiac output index. IN CONCLUSION value of cTnI level assessed 24 hours post-surgery was a reliable predictor of death following LTx with optimal cut-off value of 0.215 ng/mL. The surgery time was the most important predictor of cTnI elevation.

[1]  Ewout W Steyerberg,et al.  Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints , 2014, BMC Medical Research Methodology.

[2]  D. Snipelisky,et al.  Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation , 2013, Journal of transplantation.

[3]  E. Bernardi,et al.  Postoperative troponin T elevation as a predictor of early acute kidney injury after orthotopic liver transplantation: a preliminary retrospective study. , 2012, Transplantation proceedings.

[4]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[5]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[6]  G. Guyatt,et al.  Prognostic Value of Troponin and Creatine Kinase Muscle and Brain Isoenzyme Measurement after Noncardiac Surgery: A Systematic Review and Meta-analysis , 2011, Anesthesiology.

[7]  J. Heimbach,et al.  Predictors of cardiovascular events after liver transplantation: A role for pretransplant serum troponin levels , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  L. Kritharides,et al.  Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis. , 2010, Pharmacology & therapeutics.

[9]  J. Heimbach,et al.  Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  J. van Kuijk,et al.  Perioperative cardiac damage in vascular surgery patients. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  M. Chobanian,et al.  New-onset diabetes after transplantation: a review of recent literature , 2009, Current opinion in organ transplantation.

[12]  K. Zieniewicz,et al.  Correlation between selected prognostic factors and postoperative course in liver transplant recipients. , 2009, Transplantation proceedings.

[13]  M. Seeberger,et al.  A Preliminary Report on the Prognostic Significance of Preoperative Brain Natriuretic Peptide and Postoperative Cardiac Troponin in Patients Undergoing Major Vascular Surgery , 2009, Anesthesia and analgesia.

[14]  W. Lim,et al.  Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. , 2008, Age and ageing.

[15]  Fred S Apple,et al.  Biomarkers in acute cardiac disease: the present and the future. , 2006, Journal of the American College of Cardiology.

[16]  Gang-jian Luo,et al.  Perioperative changes of ventricular function and three indicators of myocardial injury during orthotopic liver transplantation. , 2006, Chinese medical journal.

[17]  L. Goldman,et al.  Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review , 2005, Canadian Medical Association Journal.

[18]  M. Zoli,et al.  Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[19]  J. Sear,et al.  Peri‐operative troponin I concentration as a marker of long‐term postoperative adverse cardiac outcomes – A study in high‐risk surgical patients , 2004, Anaesthesia.

[20]  M. Pfisterer,et al.  Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. , 2003, Journal of the American College of Cardiology.

[21]  Charles Weissman,et al.  Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. , 2003, Journal of the American College of Cardiology.

[22]  R. Moreau,et al.  Elevated circulating cardiac troponin I in patients with cirrhosis , 1999, Hepatology.

[23]  W. L. Howell,et al.  The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17,731 autopsies. , 1960, American heart journal.

[24]  B. Fellström.  Risk Factors for and Management of Post-Transplantation Cardiovascular Disease , 2012, BioDrugs.

[25]  P. Devereaux,et al.  Troponin T level and mortality risk after noncardiac surgery: practical implications of the VISION study. , 2012, Polskie Archiwum Medycyny Wewnetrznej.